Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The aim of our trial is to try to switch patients with permanent neonatal diabetes mellitus
due to a Kir6.2 or SUR1 activating mutation from subcutaneous insulin to oral glibenclamide
therapy.